---
title: "Clearmind Medicine Inc. (CMND.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CMND.US.md"
symbol: "CMND.US"
name: "Clearmind Medicine Inc."
industry: "制药"
---

# Clearmind Medicine Inc. (CMND.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [www.clearmindmedicine.com](https://www.clearmindmedicine.com) |

## Company Profile

Clearmind Medicine Inc.是一家临床阶段的制药公司，开发新型迷幻药物以治疗被忽视的健康问题。该公司开发针对酒精使用障碍、酗酒和饮食失调的治疗方案，以及减肥、肥胖和代谢综合症、焦虑障碍、创伤后应激障碍、抑郁症和难治性抑郁症的治疗。它开发了 MEAI 化合物用于治疗酒精使用障碍、肥胖和代谢疾病，以及一种酒精替代消费产品；并且 CM-CMND-001 正在进行 I/IIa 期临床试验，用于治疗酒精使用障碍。此外，该公司与 SciSparc Ltd.有合作关系

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.46 | 87/257 | - | - | - |
| PB | 1.50 | 68/257 | 3.80 | 2.21 | 1.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CMND.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CMND.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CMND.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.